Due to the nascent nature of Zika Virus research reagents specific for the Zika Virus such as monoclonal antibodies are not widely available. FSU researchers have produced monoclonal antibodies to the Zika virus. These monoclonal antibodies are targeted to the envelope proteins NS1 and NS5. They enable detection of Zika infection, development of diagnostics, and can also be used as control reagents in research.
